On Wednesday, Shares of Medtronic PLC (NYSE:MDT), gained 2.86% to $71.52.
Medtronic declared financial results for its first quarter of fiscal year 2016, which ended July 31, 2015.
The company stated first quarter worldwide revenue of $7.274 billion, an improvement of 12 percent counting the extra week benefit. The extra selling week is a result of the company`s 52-53 week fiscal year calendar, which occurs every six years. While it is difficult to calculate an exact impact from the extra week, the company estimates that it benefitted first quarter comparable, constant currency revenue growth by about 6 percentage points. After adjusting for the estimated benefit of the extra selling week, first quarter worldwide revenue grew at the upper-end of the mid-single digit range. Foreign currency translation had a negative $529 million impact on revenue. As stated, revenue raised 70 percent when contrast to the $4.273 billion stated by Medtronic, Inc. in the first quarter of fiscal year 2015. As detailed in the attached table, first quarter non-GAAP income and diluted earnings per share were $1.462 billion and $1.02, an improvement of 47 percent and 3 percent, respectively. As stated, first quarter net income and diluted earnings per share were $820 million and $0.57, a decrease of 6 percent and 34 percent, respectively.
U.S. revenue of $4.142 billion represented 57 percent of company revenue and raised 14 percent, high-single digit growth adjusted for the extra week, or 78 percent as stated. Non-U.S. developed market revenue of $2.197 billion represented 30 percent of company revenue and raised 10 percent, mid-single digit growth adjusted for the extra week, or 58 percent as stated. Emerging market revenue of $935 million represented 13 percent of company revenue and raised 14 percent, high-single digit growth adjusted for the extra week, or 71 percent as stated.
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products.
Shares of Citizens Financial Group Inc (NYSE:CFG), inclined 1.86% to $24.13, during its last trading session.
Citizens Financial Group declared it has been ranked second in the nation among home loan servicers for client satisfaction in a study conducted by J.D. Power.
According to the J.D. Power 2015 U.S. Primary Mortgage Servicer Satisfaction Study, Citizens scored 50 points above the industry average.
“Delivering top-notch customer service is a key component of our commitment to provide customers with the best possible banking experience, and it is gratifying that we have been recognized by J.D. Power,” said Brad Conner, Vice Chairman, and Head of Consumer Banking. “These findings reflect the investments we’ve made not only in our mortgage business, but across the entire bank, to assist our customers bank better.”
Designated one of the Most Reputable Banks in the country by American Banker/Reputation Institute in 2015, Citizens also has consistently received national recognition from industry analysts at Javelin Associates for the quality of its mobile banking apps. In addition, MONEY Magazine recently selected Citizens Bank as one of nation’s best banks in its 2014 list of “The Best Banks in America,” recognizing the company for its level of customer convenience. Citizens won similar honors from MONEY® Magazine in 2013 in the customer experience category.
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, N.A. and Citizens Bank of Pennsylvania that provide retail and commercial banking products and services in the United State
Finally, J M Smucker Co (NYSE:SJM), ended its last trade with 1.42% gain, and closed at $115.64.
The J. M. Smucker Company, declared results for the first quarter ended July 31, 2015, of its 2016 fiscal year. All comparisons are to the first quarter of the preceding fiscal year, unless otherwise noted.
EXECUTIVE SUMMARY
Net sales raised $628.2 million, or 47 percent, reflecting the contribution of Big Heart Pet Brands attained in fiscal 2015, and the Company’s U.S. retail launch of Dunkin’ Donuts® K-Cup pods during the quarter.
Net income per diluted share was in line with the preceding year, as the benefit from Big Heart operations was offset by higher interest expense and the impact of additional shares outstanding.
Non-GAAP income per diluted share was $1.32, a decrease of 1 percent.
Adjusted non-GAAP income per diluted share, which excludes amortization, was $1.60, an improvement of 7 percent.
The Company maintained its fiscal 2016 earnings outlook with non-GAAP income per diluted share predictable to range from $5.65 to $5.80, and adjusted non-GAAP income per diluted share predictable to range from $6.80 to $6.95.
The Company reconfirmed its synergy target related to the Big Heart acquisition of $200 million by the end of fiscal 2018.
The J. M. Smucker Company manufactures and markets branded food products worldwide. It operates through four segments: U.S. Retail Coffee; U.S. Retail Consumer Foods; U.S. Retail Pet Foods; and International, Foodservice, and Natural Foods.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
